Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$86.10

-3.45 (-3.85%)

08:10
07/18/17
07/18
08:10
07/18/17
08:10

Puma Biotechnology price target raised to $118 from $105 at Stifel

Stifel analyst Thomas Shrader raised his price target on Puma after the company announced that its neratinib drug for breast cancer had been approved. The analyst says the company now probably has to decide whether to build a sales force or sell itself. He thinks that the drug's "surprisingly broad label" has made the company more attractive to potential acquirers. Shrader keeps a Buy rating on the shares.

  • 21

    Jul

PBYI Puma Biotechnology
$86.10

-3.45 (-3.85%)

07/10/17
07/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. SeaSpine (SPNE) initiated with a Buy at H.C. Wainwright. 2. Puma Biotechnology (PBYI) resumed with an Outperform at Leerink. 3. SCYNEXIS (SCYX) initiated with a Buy at Roth Capital. 4. Tabula Rasa HealthCare (TRHC) initiated with a Buy at Chardan. 5. Matinas BioPharma (MTNB) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/17
SBSH
07/18/17
NO CHANGE
Target $114
SBSH
Buy
Citi ups Puma target to $114 following FDA approval of Nerlynx
Citi analyst Yigal Nochomovitz raised his price target for Puma Biotechnology to $114 from $105 after the FDA approved the company's breast cancer drug Nerlynx. The label is broad and the required two cycles of prophylaxis is "fully within expectations," Nochomovitz tells investors in a research note. He notes that his takeout scenario moves to $143 per share from $136. The analyst keeps a Buy rating on Puma shares. The stock traded up 7% to $92.50 last night in the after-hours.
07/18/17
JPMS
07/18/17
NO CHANGE
JPMS
Overweight
Puma's label for Nerlynx a best case outcome, says JPMorgan
JPMorgan analyst Cory Kasimov views the label for Puma Biotechnology's breast cancer drug Nerlynx as a best case outcome. The label does not limit the patient population to HR+, as many investors expected, and does not include a boxed warning as diarrhea is in the warnings and precautions section, Kasimov tells investors in a research note. The analyst sees room for the shares to move "materially higher" given the "scarcity value of an approved and unencumbered" oncology asset as well as the 20% short interest in the name. He reiterates an Overweight rating on Puma Biotechnology.
07/18/17
FBCO
07/18/17
NO CHANGE
Target $118
FBCO
Outperform
Puma Biotechnology price target raised to $118 from $90 at Credit Suisse
Credit Suisse analyst Alethia Young raised her price target for Puma Biotechnology to $118 from $90, saying she is moving her base case to an M&A DCF because she thinks that this remains the likely outcome from here. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

UCFC

United Community Financial

$9.77

-0.18 (-1.81%)

16:21
10/17/17
10/17
16:21
10/17/17
16:21
Earnings
United Community Financial reports Q3 EPS 15c, consensus 15c »

Reports Q3 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

HCLP

Hi-Crush Partners

$8.95

0.25 (2.87%)

16:21
10/17/17
10/17
16:21
10/17/17
16:21
Hot Stocks
Hi-Crush Partners resumes dividend with 15c payout, announces $100M buyback »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BBG

Bill Barrett

$4.36

0.15 (3.56%)

16:21
10/17/17
10/17
16:21
10/17/17
16:21
Hot Stocks
Bill Barrett sees cash commodity derivative gain of $7.3M in Q3 »

Bill Barrett Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 14

    Nov

CLR

Continental Resources

$37.31

-0.11 (-0.29%)

16:20
10/17/17
10/17
16:20
10/17/17
16:20
Hot Stocks
Continental Resources sells 1M barrels of Bakken oil for export to China »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

VIX

Volatility Index S&P 500 Options

16:20
10/17/17
10/17
16:20
10/17/17
16:20
Options
Closing CBOE SPX and VIX Index summary for October 17th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$51.10

-0.61 (-1.18%)

16:19
10/17/17
10/17
16:19
10/17/17
16:19
Hot Stocks
Mercury Systems awarded $4.7M in orders for airborne radio frequency subsystems »

Mercury Systems received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 24

    Oct

  • 07

    Nov

$NSD

NASDAQ Market Internals

16:17
10/17/17
10/17
16:17
10/17/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
10/17/17
10/17
16:16
10/17/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$199.48

-3.2 (-1.58%)

, UNH

UnitedHealth

$203.92

10.72 (5.55%)

16:15
10/17/17
10/17
16:15
10/17/17
16:15
General news
On The Fly: Top stock stories for Tuesday »

Stocks opened little…

NFLX

Netflix

$199.48

-3.2 (-1.58%)

UNH

UnitedHealth

$203.92

10.72 (5.55%)

JNJ

Johnson & Johnson

$140.75

4.63 (3.40%)

GS

Goldman Sachs

$236.08

-6.335 (-2.61%)

MS

Morgan Stanley

$49.13

0.19 (0.39%)

AET

Aetna

$155.91

4.47 (2.95%)

ANTM

Anthem

$187.29

3.53 (1.92%)

CNC

Centene

$93.78

2.86 (3.15%)

CI

Cigna

$187.20

2.21 (1.19%)

HUM

Humana

$240.54

3.37 (1.42%)

MOH

Molina Healthcare

$61.54

1.675 (2.80%)

WCG

WellCare

$174.06

6.14 (3.66%)

CYH

Community Health

$6.44

0.54 (9.15%)

HCA

HCA Healthcare

$76.81

1.62 (2.15%)

LPNT

LifePoint

$56.20

0.4 (0.72%)

THC

Tenet

$13.59

0.68 (5.27%)

UHS

Universal Health

$108.44

2.84 (2.69%)

HOG

Harley-Davidson

$47.51

0.94 (2.02%)

IONS

Ionis Pharmaceuticals

$63.85

2.7 (4.42%)

FCX

Freeport McMoRan

$14.93

-0.34 (-2.23%)

IPXL

Impax

$19.30

-0.65 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

IBM

IBM

$146.41

-0.39 (-0.27%)

16:14
10/17/17
10/17
16:14
10/17/17
16:14
Hot Stocks
IBM reports Q3 Cognitive solutions revenue $4.4B, up 3% ex-currency »

Reports Q3 Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

16:14
10/17/17
10/17
16:14
10/17/17
16:14
General news
Treasury International Capital Foreign Demand for Long-Term U.S. Securities data reported »

August Treasury…

LLESY

Lendlease Group

$14.60

0.026 (0.18%)

16:14
10/17/17
10/17
16:14
10/17/17
16:14
Downgrade
Lendlease Group rating change  »

Lendlease Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$146.40

-0.4 (-0.27%)

16:13
10/17/17
10/17
16:13
10/17/17
16:13
Earnings
IBM backs FY17 adjusted EPS view of at least $13.80, consensus $13.75 »

Operating diluted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

IBM

IBM

$146.43

-0.37 (-0.25%)

16:13
10/17/17
10/17
16:13
10/17/17
16:13
Hot Stocks
IBM reports Q3 cloud revenues up 20% to $4.1B »

Third-quarter cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

IBM

IBM

$146.45

-0.35 (-0.24%)

16:12
10/17/17
10/17
16:12
10/17/17
16:12
Earnings
IBM reports Q3 adjusted EPS $3.30, consensus $3.28 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

COTY

Coty

$16.01

-0.82 (-4.87%)

16:12
10/17/17
10/17
16:12
10/17/17
16:12
Initiation
Coty initiated  »

Coty initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRS

Northern Trust

$91.10

-0.82 (-0.89%)

16:11
10/17/17
10/17
16:11
10/17/17
16:11
Hot Stocks
Northern Trust CEO Frederick Waddell to step down »

Northern Trust announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

LRCX

Lam Research

$194.55

2.19 (1.14%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Earnings
Lam Research sees Q2 EPS $3.65, +/- 12c, consensus $3.33 »

Sees Q2 revenue $2.55B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CREE

Cree

$29.34

0.06 (0.20%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Earnings
Cree sees Q2 adjusted EPS (1c)-4c, consensus 7c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PTX

Pernix Therapeutics

$2.76

-0.05 (-1.78%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Hot Stocks
Pernix Therapeutics CFO Graham Miao to resign at the end of the year »

Pernix Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.43

-0.0128 (-2.88%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Syndicate
Breaking Syndicate news story on Houston American Energy »

Houston American Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Technical Analysis
Technical View: Select Comfort drops after earnings miss »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Earnings
MobileIron sees Q3 revenue $42M-$43M, consensus $45.22M »

Sees Q3: Gross billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCSG

Healthcare Services

$54.37

-0.08 (-0.15%)

16:08
10/17/17
10/17
16:08
10/17/17
16:08
Hot Stocks
Healthcare Services increases dividend to 19c per share »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

16:08
10/17/17
10/17
16:08
10/17/17
16:08
Hot Stocks
MobileIron CEO Barry Mainz to leave, Simon Biddiscombe to succeed »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.